Activ8rlives News & Case Studies

 
Latest News from Activ8rlives

‘Aggressive’ blood pressure control helps beat dementia, study finds

New research supports the evidence that high blood pressure or hypertension, sometimes called the ‘silent killer’, is pointing to a lowered chance of developing mild cognitive impairment when they keep their blood pressure below 120mg. The author of the new research, Dr Walter Koroshetz, director of the National Institutes of Health’s (NIH) National Institute of […]

Posted on August 15, 2019

Asthma+me – the App being trialled to help children manage severe asthma

A new Asthma+me App is being trialled at Sheffield Children’s Hospital to help children manage their severe asthma. A partnership between Sheffield Children’s and technology company Aseptika, the innovative trial uses the newly developed Asthma+me App to help patient and parents better manage severe asthma outside of the hospital. The App allows the patient and/or […]

Posted on August 12, 2019

Asthma+me innovative technology-enabled solution for paediatric asthma is shortlisted for Best Technological Innovation: Digital

The Medtech Insight Awards 2019 have shortlisted Aseptika’s Asthma+me solution in the category of ‘Best Technological Innovation: Digital’. Asthma+me has been co-designed with a Paediatrician at an NHS Trust (UK) to support transition from treatment in a specialist paediatric clinics to community care, with the initial focus on meeting the needs of children aged 6-12 […]

Posted on August 9, 2019

Aseptika wins big at West Midlands healthcare innovation awards

Local Cambridgeshire healthcare company, Aseptika Ltd (Activ8rlives) has been awarded the Digital or Artificial Intelligence Innovation of the Year Award at the Meridian Awards – A Celebration of Innovation, for its ground-breaking Active+me patient activation programme. The Active+me programme combines group exercise classes, health coaching, peer support, PAM (Patient Activation Measure) monitoring, with Aseptika – […]

Posted on August 5, 2019

Novel medical-grade wearable patent granted to Aseptika for BuddyWOTCH

Aseptika Ltd announces that the European Patent Office has granted a patent for its medical-grade wearable, for use by patients with severe cardiovascular and respiratory diseases (EU patent number 3197354).

Posted on July 24, 2019

1 2 3 14

Latest Case Studies

Back into shape mum

Amber and her five year old son walked their way to a healthier, fitter, future, thanks to a radical new approach to fitness, which started with aiming for just 10,000 steps every day.

1 5 6 7